Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Circ Heart Fail. 2019 Mar;12(3):e005234. doi: 10.1161/CIRCHEARTFAILURE.118.005234

Figure 6. Anthracyclines are associated with a subacute decrease in cardiac mass detected by cardiac MRI in cancer patients.

Figure 6.

70 subjects from the DETECT-1 cohort analysis underwent cardiac MRI at baseline, then 1, 3, and 6 months after initiation of anthracycline-based chemotherapy. The rate of change in left ventricular mass by CMR was analyzed by constructing a linear mixed model with random intercepts and time effects using SAS 9.4. Inset shows full range of values.